Junevity

Publication of the first research to show repression of a single transcription factor can reverse cell aging

Junevity founders publish their work in PNAS in January 2026

Feb 5 • Junevity

1

1

December 2025

Junevity expands Seed funding to $20M for cell reprogramming with siRNA

New funding led by Goldcrest Capital and Godfrey Capital to advance lead candidate JUN_01 for type 2 diabetes and obesity to first-in-human studies

Dec 4, 2025 • Junevity

October 2025

GEN: Unlocking the Potential of Transcription Factors

How siRNA, omics, and AI could enable 100 new FDA approvals by 2045

Oct 6, 2025 • Junevity

February 2025

Introducing Junevity: Cell Reset for Longevity with siRNA

Co-founders John Hoekman, Janine Sengstack, Rob Cahill

Feb 13, 2025 • Junevity

1